Epitopes described in "Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin."

Reference
Article Authors:Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Article Title:Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.
Reference Detail
Reference ID:1007681
Abstract:The recent threat of an avian influenza pandemic has generated significant interest in enhancing our understanding of the events that dictate protective immunity to influenza and in generating vaccines that can induce heterosubtypic immunity. Although antigen-specific CD4 T cells are known to play a key role in protective immunity to influenza through the provision of help to B cells and CD8 T cells, little is known about the specificity and diversity of CD4 T cells elicited after infection, particularly those elicited in humans. In this study, we used HLA-DR transgenic mice to directly and comprehensively identify the specificities of hemagglutinin (HA)-specific CD4 T cells restricted to a human class II molecule that were elicited following intranasal infection with a strain of influenza virus that has been endemic in U.S. human populations for the last decade. Our results reveal a surprising degree of diversity among influenza virus-specific CD4 T cells. As many as 30 different peptides, spanning the entire HA protein, were recognized by CD4 T cells, including epitopes genetically conserved among H1, H2, and H5 influenza A viruses. We also compared three widely used major histocompatibility class II algorithms to predict HLA-DR binding peptides and found these as yet inadequate for identifying influenza virus-derived epitopes. The results of these studies offer key insights into the spectrum of peptides recognized by HLA-DR-restricted CD4 T cells that may be the focus of immune responses to infection or to experimental or clinical vaccines in humans.
Affiliations:David H. Smith Center for Vaccine Biology and Immunology, Aab Institute, Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.
Date:2007
Reference Type:Literature
PubMed ID:17507491
Journal:J Virol
Journal Volume:81
Article Pages:7608-19
Journal ISSN:1098-5514
Article Chemical List:HLA-DR1 Antigen;Hemagglutinins, Viral
Article MeSH List:Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes(immunology ); Cell Line; Enzyme-Linked Immunosorbent Assay; HLA-DR1 Antigen(genetics; physiology ); Hemagglutinins, Viral(pharmacology ); Mice; Mice, Transgenic; Molecular Sequence Data; Orthomyxoviridae(metabolism ); Sequence Homology, Amino Acid
Curation Last Updated:2010-10-26 00:59:48